Fu, Yunfeng <br/><br/>
Alisertib induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells.  [electronic resource] 

 -  Molecular medicine reports  Jul 2016 
 - 394-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-3004 
<br/><br/><label>Standard No.: </label>10.3892/mmr.2016.5249  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--metabolism<br/>Apoptosis--drug effects<br/>Autophagy--drug effects<br/>Azepines--chemistry<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Humans<br/>Leukemia<br/>Protein Kinase Inhibitors--chemistry<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Pyrimidines--chemistry<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--metabolism<br/>p38 Mitogen-Activated Protein Kinases--metabolism